Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Martinowitz

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 2, 2007
Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patientsY Maor, P Calès, D Bashari, et al.
Blood|December 1, 1990
The molecular genetic analysis of hemophilia A: a directed search strategy for the detection of point mutations in the human factor VIII geneJ K Pattinson, D S Millar, J H McVey, et al.
Journal of Thrombosis and Haemostasis : JTH|September 29, 2015
Rediscovering the wound hematoma as a site of hemostasis during major arterial hemorrhageN J White, E Mehic, X Wang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 12, 1999
Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessmentO Salomon, D M Steinberg, A Zivelin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 8, 2013
Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacyS R Lentz, M Misgav, M Ozelo, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 7, 2012
Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysisU Martinowitz, A Shapiro, D V Quon, et al.
Thrombosis and Haemostasis|April 26, 2014
Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effectM Morfini, A Batorova, G Mariani, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
Experiences with continuous infusion of recombinant activated factor VIIS Schulman, R d'Oiron, U Martinowitz, et al.
Human Genetics|December 29, 2000
Molecular analysis of the genotype-phenotype relationship in factor VII deficiencyD S Millar, G Kemball-Cook, J H McVey, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 2, 2007
Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patientsY Maor, P Calès, D Bashari, et al.
Blood|December 1, 1990
The molecular genetic analysis of hemophilia A: a directed search strategy for the detection of point mutations in the human factor VIII geneJ K Pattinson, D S Millar, J H McVey, et al.
Journal of Thrombosis and Haemostasis : JTH|September 29, 2015
Rediscovering the wound hematoma as a site of hemostasis during major arterial hemorrhageN J White, E Mehic, X Wang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 12, 1999
Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessmentO Salomon, D M Steinberg, A Zivelin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 8, 2013
Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacyS R Lentz, M Misgav, M Ozelo, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 7, 2012
Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysisU Martinowitz, A Shapiro, D V Quon, et al.
Thrombosis and Haemostasis|April 26, 2014
Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effectM Morfini, A Batorova, G Mariani, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
Experiences with continuous infusion of recombinant activated factor VIIS Schulman, R d'Oiron, U Martinowitz, et al.
Human Genetics|December 29, 2000
Molecular analysis of the genotype-phenotype relationship in factor VII deficiencyD S Millar, G Kemball-Cook, J H McVey, et al.
Pageof 14